Phil Sharp

Overview

Nobel Prize-winning MIT scientist, co-founder of Biogen and founder of Alnylam, who predicted in 2008-2009 that an explosion of therapeutic modalities would define the third revolution of biotech. Phil Sharp, a Nobel Prize winner from MIT, co-founded Biogen and founded Alnylam Pharmaceuticals, and served on the Scientific Advisory Board of Danaher. In 2008-2009 Phil Sharp predicted a third revolution in biotech — the intersection of molecular engineering, genomics, and information technology/computational sciences — that would produce an explosion of therapeutic modalities. (Segment 1 (00:00-05:00))